Nppa

Rediff.com » News » Nppa

News for Nppa

News
Business

Why Dolo, Saridon, Calpol Will Have QR Codes

IMAGE: Kindly note the image has been posted only for representational purposes. Photograph: Kind courtesy Castorly Stock/Pexels.com and Pixabay.com The top 300 pharmaceutical brands in the......

Trade margins capped at 70% for oximeters, BP meters, other medical devices

The medical devices, which have been in high demand during the Covid-19 pandemic, will now see a drop in prices, as the earlier margins were up to 709 per cent for some of these products. IMAGE:......

3 lakh remdesivir to be produced daily in 15 days: Govt

The government plans to double the production of antiviral drug remdesivir to around 3 lakh vials per day over the next 15 days, to make it available readily for the treatment of COVID-19.......

Govt waives import duty on Remdesivir

Amid surging COVID-19 cases in the country, the government on Tuesday waived customs duty on Remdesivir, its raw materials and other components used to make the antiviral drug. The move would help......

Masks, hand sanitiser declared 'essential commodities'

The government on Friday declared face masks and hand sanitisers as essential commodities for the next 100 days as it stepped up efforts to boost supply and prevent hoarding of these items in its......

Why Drug Prices Won't Increase This Year

The government has been stringent with pricing changes.Prices of 651 essential medicines came down from April 1, 2023 by 6.73 per cent with the government capping ceiling prices of these drugs.......

GOOD News! No Drug Price Hike In 2024

For the consumer, there would be practically no impact on prices of essential medicines this year. IMAGE: Kindly note the image has been posted only for representational purposes. Photograph: Kind......

NPPA heat on hospitals for failing to provide stent details

The regulator is now probing 24 hospitals, including Max Hospital in New Delhi and Lilavati in Mumbai, for allegedly overcharging patients for stents The National Pharmaceutical Pricing Authority......

NPPA pulls up cipla, Ranbaxy for overcharging

Leading pharmaceutical firms such as Cipla and Ranbaxy are among the firms pulled up by the drug price regulator National Pharmaceuticals Pricing Authority (NPPA) for overcharging. According to the......

NPPA slaps Rs 300-crore penalty on Novartis

Drug major Novartis has been slapped with a Rs 300-crore (Rs 3 billion) penalty by drug regulator NPPA for overcharging consumers on sale of Voveran, its best-selling painkiller medicine. The Swiss......

Nppa

News for Nppa

Why Dolo, Saridon, Calpol Will Have QR Codes

Trade margins capped at 70% for oximeters, BP meters, other medical devices

3 lakh remdesivir to be produced daily in 15 days: Govt

Govt waives import duty on Remdesivir

Masks, hand sanitiser declared 'essential commodities'

Why Drug Prices Won't Increase This Year

GOOD News! No Drug Price Hike In 2024

NPPA heat on hospitals for failing to provide stent details

NPPA pulls up cipla, Ranbaxy for overcharging

NPPA slaps Rs 300-crore penalty on Novartis

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS